Clinical Trials Sponsored by Orpyx Medical Technologies Inc.

Total 117 results

Orpyx Medical Technologies Inc.

Not yet recruiting

WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention (WIREDUP)

Diabetes | Diabetic Foot | Diabetic Foot Ulcer | Peripheral Neuropathy
Orpyx Medical Technologies Inc.

Completed

Monitoring Physiologic Parameters in Individuals With Diabetic Peripheral Neuropathy

Diabetic Foot | Diabetic Peripheral Neuropathy

United States
University of Alberta
Alberta Innovates Health Solutions; Orpyx Medical Technologies Inc.

Completed

Diabetes Foot Care Clinical Pathway - Orpyx Medical Technologies (DFCCP-Orpyx)

Diabetic Foot Ulcer

Canada
GT Medical Technologies, Inc.

Not yet recruiting

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy (PATHWAyS)

Glioblastoma
GT Medical Technologies, Inc.

Recruiting

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

Glioblastoma

United States
GT Medical Technologies, Inc.

Recruiting

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain Tumor | Brain Tumor, Recurrent | Brain Tumor, Primary | Brain Tumor - Metastatic | Brain Tumor, Adult: Glioblastoma | Brain Tumor, Adult Meningioma

United States
GT Medical Technologies, Inc.

Recruiting

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Brain Metastases

United States
Delphinus Medical Technologies, Inc.

Completed

Delphinus SoftVue Prospective Case Collection - ARM 1 (SV PCC ARM1)

Breast Neoplasms

United States
Rockwell Medical Technologies, Inc.

Completed

Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

End Stage Renal Disease

United States
Laborie Medical Technologies Inc.

Completed

T-DOC® 5 Fr Pediatric Clinical Investigation

Incontinence, Urge

United States
Laborie Medical Technologies Inc.

Completed

Air-charged vs Water-filled Catheters (Bonn)

Urodynamics

Germany
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers (RMFPC-12)

End Stage Renal Disease

United States
Prollenium Medical Technologies Inc.

Completed

Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF

Nasolabial Fold Correction

United States
Rockwell Medical Technologies, Inc.

Completed

Triferic Pediatric Pharmacokinetic Protocol

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (PRIME)

End Stage Renal Disease

United States, Puerto Rico
Magnolia Medical Technologies, Inc.

Terminated

Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters

Septicemia

United States
HemCon Medical Technologies, Inc

Completed

A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing

Tooth Extractions

United States
Kestra Medical Technologies, Inc.

Recruiting

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS) (ACE-PAS)

Sudden Cardiac Arrest

United States
Rockwell Medical Technologies, Inc.

Not yet recruiting

Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy

Iron Deficiency Anemia
Rockwell Medical Technologies, Inc.

Recruiting

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

End Stage Renal Disease

United States, Puerto Rico
4C Medical Technologies, Inc.

Recruiting

AltaValve Early Feasibility Study Protocol

Mitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral Incompetence

United States
Prollenium Medical Technologies Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment

Volume Deficit in the Mid-face

Canada
Rockwell Medical Technologies, Inc.

Completed

Triferic AVNU Infusion Via Freedom Pump During Hemodialysis

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients

End Stage Renal Disease

United States
Laborie Medical Technologies Inc.

Completed

T-DOC® NXT Clinical Investigation

Incontinence, Urge

United States
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

End Stage Renal Disease

United States
Prollenium Medical Technologies Inc.

Completed

Multicenter Double-Blind Randomized Split-Face Study to Evaluate Revanesse® Ultra vs Restylane® for Correction of NLF

Nasolabial Fold Correction
Prollenium Medical Technologies Inc.

Completed

Multicenter Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Retreatment (Retreatment)

Nasolabial Fold Correction
Rockwell Medical Technologies, Inc.

Completed

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 1)

Renal Failure Chronic Requiring Hemodialysis

United States, Puerto Rico
Rockwell Medical Technologies, Inc.

Completed

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)

Renal Failure Chronic Requiring Hemodialysis

United States, Canada
Laborie Medical Technologies Inc.

Completed

A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use

Urology
Laborie Medical Technologies Inc.

Terminated

Tetra-NIRS Clinical Study

Overactive Bladder | Lower Urinary Tract Symptoms

United States, Canada, United Kingdom
HemCon Medical Technologies, Inc

Withdrawn

Study of Hemostatic Efficacy of the HemCon Dental Dressing in a Population Treated With Anticoagulant Medications

Tooth Extractions

United States
Pathway Medical Technologies Inc.

Completed

A Study to Collect Intravascular Ultrasound Images Before and After Treatment With the Jetstream System

Peripheral Arterial Disease | Peripheral Vascular Disease

United States
Pathway Medical Technologies Inc.

Completed

The Pathway PVD Study for Percutaneous Peripheral Vascular Interventions

Peripheral Artery Disease
OmniSonics Medical Technologies, Inc.

Unknown

Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis (SONIC I)

Deep Vein Thrombosis
Laborie Medical Technologies Inc.

Not yet recruiting

NXT Post-Market Clinical Follow-up

Urinary Bladder, Overactive | Urinary Incontinence | Urinary Bladder, Neurogenic | Urinary Incontinence, Urge | Urinary Obstruction
Synergic Medical Technologies, Inc.

Recruiting

Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2

Parkinson Disease

United States
Synergic Medical Technologies, Inc.

Recruiting

Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease

Parkinson's Disease

United States
Laborie Medical Technologies Inc.

Completed

e۰Sense® Catheter Clinical Investigation

Urodynamics

Germany, France
Delphinus Medical Technologies, Inc.

Completed

Delphinus SoftVue Prospective Case Collection - ARM 2 (SV PCC ARM2)

Breast Neoplasms

United States
Rockwell Medical Technologies, Inc.

Completed

Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis

End-Stage Renal Disease (ESRD)

United States, Canada
Rockwell Medical Technologies, Inc.

Terminated

Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol

Iron-Refractory Iron-Deficiency Anemia
Rockwell Medical Technologies, Inc.

Completed

Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

Anemia | Chronic Kidney Disease | Peritoneal Dialysis (PD)
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers

Iron-refractory, Iron-deficiency Anemia (IRIDA)

United States
Magnolia Medical Technologies, Inc.

Completed

Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device

Septicemia

United States
Rockwell Medical Technologies, Inc.

Completed

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

End Stage Renal Disease | Chronic Kidney Disease

United States, Canada
Laborie Medical Technologies Inc.

Completed

Portable Pves Study

Lower Urinary Tract Symptoms
HemCon Medical Technologies, Inc

Withdrawn

A Clinical Study of Lyophilized Plasma in Patients on Warfarin

Anticoagulant Therapy

Clinical Trials Sponsored by Orpyx Medical Technologies Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations